Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN vs NALOXEGOL OXALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN vs NALOXEGOL OXALATE: Safety Overview

Metric NAFCILLIN NALOXEGOL OXALATE
Total FAERS Reports 215 2,212
Deaths Reported 18 154
Death Rate 8.4% 7.0%
Hospitalizations 98 335
Average Patient Age 50.7 yrs 63.7 yrs
% Female Patients 50.5% 58.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 16, 2014
Manufacturer Eugia US LLC RedHill Biopharma Ltd
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription